相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice
Chunling Yuan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes
Frits Kamp et al.
ACS CHEMICAL NEUROSCIENCE (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons
C. Baez-Becerra et al.
NEUROTOXICITY RESEARCH (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
Honghua Zheng et al.
JOURNAL OF NEUROSCIENCE (2017)
Ligands of Therapeutic Utility for the Liver X Receptors
Rajesh Komati et al.
MOLECULES (2017)
Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System
Kim L. Mertens et al.
FRONTIERS IN NEUROSCIENCE (2017)
Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo- deficient mice
Alexis Y. Carter et al.
PLOS ONE (2017)
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer's disease
M. M. Mariani et al.
SCIENTIFIC REPORTS (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms
Pham Dinh Quoc Huy et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease
A. G. Sandoval-Hernandez et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice
Angela W. Corona et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1
Masaya Tachibana et al.
EXPERIMENTAL NEUROLOGY (2016)
Effects of bile acids on neurological function and disease
Matthew McMillin et al.
FASEB JOURNAL (2016)
Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease
Shawn J. Stachel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Historical overview of nuclear receptors
Jan-Ake Gustafsson
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
Felix L. Yeh et al.
NEURON (2016)
Lack of support for bexarotene as a treatment for Alzheimer's disease
Eugene O'Hare et al.
NEUROPHARMACOLOGY (2016)
LXR activation protects hippocampal microvasculature in very old triple transgenic mouse model of Alzheimer's disease
Adrian G. Sandoval-Hernandez et al.
NEUROSCIENCE LETTERS (2016)
RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers
Kyong Nyon Nam et al.
SCIENTIFIC REPORTS (2016)
Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination
Muktha S. Natrajan et al.
BRAIN (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity
Anais Mounier et al.
JOURNAL OF NEUROSCIENCE (2015)
Nuclear Receptors License Phagocytosis by Trem2+ Myeloid Cells in Mouse Models of Alzheimer's Disease
Julie C. Savage et al.
JOURNAL OF NEUROSCIENCE (2015)
RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment
Iliya Lefterov et al.
NEUROBIOLOGY OF DISEASE (2015)
Adult Neurogenesis and the Future of the Rejuvenating Brain Circuits
Gabriel Lepousez et al.
NEURON (2015)
9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice
Ralph Ruehl et al.
PLOS GENETICS (2015)
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
Melanie Kuntz et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The Continuing Failure of Bexarotene in Alzheimer's Disease Mice
Claudia Balducci et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
Daniel M. Michaelson
ALZHEIMERS & DEMENTIA (2014)
Nuclear Receptors, RXR, and the Big Bang
Ronald M. Evans et al.
CELL (2014)
Improvement of Memory Deficits and Amyloid-β Clearance in Aged APP23 Mice Treated with a Combination of Anti-Amyloid-β Antibody and LXR Agonist
Nicholas F. Fitz et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway
Jing Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Amyloid-β Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo
Leon M. Tai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cholestenoic acids regulate motor neuron survival via liver X receptors
Spyridon Theofilopoulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Reversal of apoE4-Driven Brain Pathology and Behavioral Deficits by Bexarotene
Anat Boehm-Cagan et al.
JOURNAL OF NEUROSCIENCE (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Cerebrotendinous xanthomatosis
Ingemar Bjorkhem
CURRENT OPINION IN LIPIDOLOGY (2013)
Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood-Brain Barrier
Corbin Bachmeier et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis
Jason D. Ulrich et al.
MOLECULAR NEURODEGENERATION (2013)
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
Katherine D. LaClair et al.
MOLECULAR NEURODEGENERATION (2013)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Regulation of prostaglandin F2α, against β amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia
Jingjing Zhuang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Response to Comments on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Gary E. Landreth et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Nicholas F. Fitz et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ina Tesseur et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Karthikeyan Veeraraghavalu et al.
SCIENCE (2013)
Comment on ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Ashleigh R. Price et al.
SCIENCE (2013)
Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations
A. Arnoldi et al.
CLINICAL GENETICS (2012)
Brain Pericytes ABCA1 Expression Mediates Cholesterol Efflux but not Cellular Amyloid-β Peptide Accumulation
Julien Saint-Pol et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
LIVER X RECEPTOR ACTIVATION ATTENUATES INFLAMMATORY RESPONSE AND PROTECTS CHOLINERGIC NEURONS IN APP/PS1 TRANSGENIC MICE
W. Cui et al.
NEUROSCIENCE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Sensory Network Dysfunction, Behavioral Impairments, and Their Reversibility in an Alzheimer's β-Amyloidosis Mouse Model
Daniel W. Wesson et al.
JOURNAL OF NEUROSCIENCE (2011)
Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis
Dick Terwel et al.
JOURNAL OF NEUROSCIENCE (2011)
Liver X receptor activation restores memory in aged AD mice without reducing amyloid
Tim Vanmierlo et al.
NEUROBIOLOGY OF AGING (2011)
Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?
Michael Ogundare et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
James J. Donkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Liver X Receptor Agonist Treatment Ameliorates Amyloid Pathology and Memory Deficits Caused by High-Fat Diet in APP23 Mice
Nicholas F. Fitz et al.
JOURNAL OF NEUROSCIENCE (2010)
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Christopher K. Glass et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways
Serena Ghisletti et al.
GENES & DEVELOPMENT (2009)
ApoE promotes the proteolytic degradation of Aβ
Qingguang Jiang et al.
NEURON (2008)
Systematic gene expression mapping clusters nuclear receptors according to their function in the brain
Francoise Gofflot et al.
CELL (2007)
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
Noam Zelcer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
David R. Riddell et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
International Union of Pharmacology. LXVI. Orphan nuclear receptors
Gerard Benoit et al.
PHARMACOLOGICAL REVIEWS (2006)
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Angie L. Bookout et al.
CELL (2006)
The effects of ABCA1 on cholesterol efflux and Aβ levels in vitro and in vivo
Mark P. Burns et al.
JOURNAL OF NEUROCHEMISTRY (2006)
New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions
Joerg Mey
JOURNAL OF NEUROBIOLOGY (2006)
The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease
V Hirsch-Reinshagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor
J Ruiz et al.
JOURNAL OF LIPID RESEARCH (2005)
Inactivation of liver X receptor β leads to adult-onset motor neuron degeneration in male mice
S Andersson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The liver X receptor ligand T0901317 decreases amyloid β production in vitro and in a mouse model of Alzheimer's disease
T Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ATP-binding cassette transporter Al and its role in HDL formation
JY Lee et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
ApoE and clusterin cooperatively suppress Aβ levels and deposition:: Evidence that ApoE regulates extracellular Aβ metabolism in vivo
RB DeMattos et al.
NEURON (2004)
ApoAl deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-β pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
AM Fagan et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain
V Hirsch-Reinshagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
SE Wahrle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
M Koistinaho et al.
NATURE MEDICINE (2004)
Expression of liver X receptor target genes decreases cellular amyloid β peptide secretion
Y Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
The nuclear receptor superfamily
M Robinson-Rechavi et al.
JOURNAL OF CELL SCIENCE (2003)
Liver X receptors in the central nervous system:: From lipid homeostasis to neuronal degeneration
L Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation
CL Wellington et al.
LABORATORY INVESTIGATION (2002)
Presenilin, Notch, and the genesis and treatment of Alzheimer's disease
DJ Selkoe
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
